Filing Flows › Strata Critical Medical (SRTA) › Q4 2025
Strata Critical Medical (SRTA) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 3, 2026
Strata Critical Medical (SRTA) reported revenue of $66.8M for the fourth quarter 2025 (Q4 2025), +84% from a year earlier and +35% from the quarter before. Operating margin was -9.6%, net loss $8.8M (13.2% of revenue).
Strata Critical Medical, Q4 2025: revenue $66.8M (+84% year over year), operating margin -9.6%, net loss $8.8M, operating cash flow −$8.3M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $66.8M | +35% | +84% |
| Operating profit | −$6.4M | — | — |
| Net earnings | −$8.8M | -115% | — |
| Operating cash flow | −$8.3M | — | — |
What changed
Revenue was $66.8M in Q4 2025, up 84% year over year and up 35% from the previous quarter.
Operating costs exceeded revenue by $6.4M, an operating margin of -9.6%. Total costs grew 73% against revenue growth of 84%. The quarter ended with a net loss of $8.8M, after a profit of $57.4M the previous quarter.
Operating cash flow was −$8.3M. Non-cash charges added back $3.0M of depreciation and amortization and $6.6M of share-based compensation. Working capital and other items used $9.1M. Capital expenditures of $1.8M exceeded it, leaving free cash flow of −$10.2M.
Questions
What was Strata Critical Medical's revenue in the fourth quarter 2025?
Strata Critical Medical (SRTA) reported revenue of $66.8M for the fourth quarter 2025 (Q4 2025), +84% from a year earlier and +35% from the quarter before.
Was Strata Critical Medical profitable in the fourth quarter 2025?
Operating loss was $6.4M (-9.6% of revenue) and net loss $8.8M.